Discover 221 paid clinical trials in Columbia, South Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 221
Active & Responsive
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: Columbia SC, Rock Hill SC, Charlotte NC,
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Sex: All
Age: 12+
Code: NCT06664619
Phase3, Recruiting
Active & Responsive
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
for
Osteoarthritis (OA) of the Knee
Location: Columbia SC, Charleston SC, Daytona Beach FL,
Sponsor: Pacira Pharmaceuticals, Inc
Sex: All
Age: 45 - 70+
Code: NCT06884865
Phase2, Recruiting
Active & Responsive
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
for
Narcolepsy Type 1
Location: Columbia SC, Huntersville NC, Denver NC, Charleston SC,
Sponsor: Takeda
Sex: All
Age: 16 - 70
Code: NCT05816382
Phase2, Phase3, Recruiting
Active & Responsive
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for
Coronavirus Disease (COVID-19)
Location: Columbia SC, Monroe NC, Charlotte NC, Lawrenceville GA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06667700
Phase3, Recruiting
New
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Columbia SC, Charleston SC, Durham NC, Atlanta GA,
Sponsor: University of Cincinnati
Sex: All
Age: 18+
Code: NCT05338697
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18 - 70+
Code: NCT07179016
Recruiting
New
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: West Columbia SC, Matthews NC, Charlotte NC,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
New
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO